Global Assisted Reproductive Technology (ART) Market Growth (Status and Outlook) 2023-2029

Global Assisted Reproductive Technology (ART) Market Growth (Status and Outlook) 2023-2029

Assisted Reproductive Technology (ART) is the technology used to achieve pregnancy in procedures such as fertility medication, in vitro fertilization and surrogacy. It is reproductive technology used primarily for infertility treatments, and is also known as fertility treatment. It mainly belongs to the field of reproductive endocrinology and infertility, and may also include intracytoplasmic sperm injection (ICSI) and cryopreservation. Some forms of ART are also used with regard to fertile couples for genetic reasons (preimplantation genetic diagnosis). ART is also used for couples who are discordant for certain communicable diseases; for example, HIV to reduce the risk of infection when a pregnancy is desired.

LPI (LP Information)' newest research report, the “Assisted Reproductive Technology (ART) Industry Forecast” looks at past sales and reviews total world Assisted Reproductive Technology (ART) sales in 2022, providing a comprehensive analysis by region and market sector of projected Assisted Reproductive Technology (ART) sales for 2023 through 2029. With Assisted Reproductive Technology (ART) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Assisted Reproductive Technology (ART) industry.

This Insight Report provides a comprehensive analysis of the global Assisted Reproductive Technology (ART) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Assisted Reproductive Technology (ART) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Assisted Reproductive Technology (ART) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Assisted Reproductive Technology (ART) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Assisted Reproductive Technology (ART).

The global Assisted Reproductive Technology (ART) market size is projected to grow from US$ 19620 million in 2022 to US$ 29270 million in 2029; it is expected to grow at a CAGR of 5.9% from 2023 to 2029.

North America is also expected to witness growth in the coming years. This is due to people awareness towards various fertility options, government support for the in-vitro fertilization and various technological and procedure up gradation. For instance, in August 2015 Ovascience’s treatment named AUGMENT has been reported to have rejuvenated women’s aging egg cells and provided benefits to eggs with poor quality. In February 2015, the scientist of U.S. who invented the three parent IVF procedure requested the Food and Drug Administration (FDA) to grant permission for its clinical trials as age related infertility.

This report presents a comprehensive overview, market shares, and growth opportunities of Assisted Reproductive Technology (ART) market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
In-Vitro Fertilization (IVF)
Artificial Insemination (AI)

Segmentation by application
Women Younger Than Age 35
Women Older Than Age 35

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Irvine Scientific
Origio a/s
Vitro Life
Esco Micro Pte. Ltd.
IVFtech ApS
Research Instruments
Genea Limited
Smiths Medical
Thermo Fisher Scientific, Inc.
Cook Medical

Please note: The report will take approximately 2 business days to prepare and deliver.